WELLINGTON MANAGEMENT GROUP LLP

Position in NUVB — Nuvation Bio Inc.

CIK 902219 Boston, MA

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,065,634

+$1,182,138 QoQ

Shares Held

715,781

+6.5% QoQ

Ownership

0.204%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 242 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 70% None 30%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. NUVB ranks #95 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,247,658	$1,613,209,155
2	ARGX	Argenx SE	930,548	$863,334,513
3	REGN	Regeneron Pharmaceuticals, Inc.	1,270,087	$791,950,042
4	RVMD	Revolution Medicines, Inc.	3,843,415	$719,794,757
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,110,407	$635,295,816
6	IONS	Ionis Pharmaceuticals Inc	7,651,415	$606,680,693
7	CYTK	Cytokinetics Inc	6,931,770	$590,517,483
8	MDGL	Madrigal Pharmaceuticals, Inc.	825,714	$443,367,129

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,065,634	715,781	+6.5%	Shares	Defined	2026-08-14
2026-03-31	$2,883,496	672,144	-25.3%	Shares	Defined	2026-05-15
2025-12-31	$8,063,890	899,988	+3.6%	Shares	Defined	2026-02-17
2025-09-30	$3,213,559	868,530	+18.4%	Shares	Defined	2025-11-14
2025-06-30	$1,430,406	733,542	+5.9%	Shares	Defined	2025-08-14
2025-03-31	$1,219,104	692,673	+2.5%	Shares	Defined	2025-05-13
2024-12-31	$1,798,223	676,024	+8.3%	Shares	Defined	2025-02-12
2024-09-30	$1,428,897	623,973	+83.3%	Shares	Defined	2024-11-14
2024-06-30	$993,765	340,331	-57.9%	Shares	Defined	2024-08-14
2021-03-31	$8,446,995	808,325	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.